Sandostatin Lar 20 mg powder and solvent for suspension for injection
Pays: Bulgarie
Langue: bulgare
Source: ИАЛ - Изпълнителната агенция по лекарствата към Министерството на Здравето на Република България
Notice patient
(PIL)
15-01-2024
Résumé des caractéristiques du produit
(SPC)
30-01-2023
Ingrédients actifs:
Октреотид
Disponible depuis:
Novartis Pharma GmbH
Code ATC:
H01CB2
DCI (Dénomination commune internationale):
Octreotide
Dosage:
20 mg powder and solvent for suspension for injection
Descriptif du produit:
Sandostatin LAR, 20 mg powder and solvent for suspension for injection
Date de l'autorisation:
2015-03-11
